RBC Capital on Biotech Shares: 'Company-Specific Volatility For Quality Names May Be Overdone' Sep 11, 2025 08:18AM
Nuvation Bio Inc (NUVB) PT Lowered to $6 at RBC Capital Jun 17, 2025 10:13AM
Nuvation Bio to Participate in Upcoming Investor Conferences May 12, 2025 04:05PM
RBC Capital Explores Biotech Implications Following Cavazzoni's Departure from the FDA Jan 13, 2025 12:50PM
Nuvation Bio Inc (NUVB) PT Raised to $5 at RBC Capital Apr 17, 2024 07:06AM


Apr 6, 2021 08:26AM RBC Capital Starts Nuvation Bio Inc (NUVB) at Outperform